相关基因多态 (ABCG2) 和在患者中耐药
Ghada Abd El Wahab Khalil Ibrahim1, Maysaa Ali Abdul Khaleq2, Ahmed Hamza Ajmi3
1FACULTY OF MEDICINE, ZAGAZIG UNIVERSITY, ZAGAZIG, EGYPT.
概括
ABCG2基因的遗传变异与的风险增加有关. 该研究发现患者中ABCG2C>T异性基因型的患病率较高,这表明在疾病易感性方面可能发挥作用.
科学领域:
- 药物基因组学 药物基因组学
- 神经遗传学 神经遗传学
- 分子生物学分子生物学
背景情况:
- 影响全球数以百万计的人,部分是一种常见的形式.
- 了解的遗传基础对于开发向疗法至关重要.
- ABCG2基因在药物运输中发挥作用,并与各种疾病有关.
研究的目的:
- 研究ABCG2基因变异与部分患者对抗药物的反应之间的关联.
- 探索多个载体基因变异对结果的潜在综合影响.
主要方法:
- 一项涉及65名患者和40名健康对照者的病例控制研究.
- 进行DNA提取和多态性测试以分析ABCG2C>T (rs2231137) 多态性.
- 还包括了相关研究的数据,这些研究与ABCG2多态相相关.
主要成果:
- 对ABCG2C>T多态的异构基因型CT在患者中比对照患者更常见.
- 在ABCG2C>T等位基多态和风险增加之间观察到显著的相关性.
- 在患者和对照人群之间,在年龄,性别或抗发作药物治疗方面没有发现显著差异.
结论:
- ABCG2 C>T (rs2231137) 多态性与患的风险增加有关.
- 与对照组相比,患者更有可能携带具有C等位基因的异性CT基因型.
- 这些发现凸显了ABCG2基因变异在易感性方面的潜在作用.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
300
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
300
Antiepileptic Drugs: Potassium Channel Activators
138
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
138
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
206
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
206
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Arteries of the Lower Limbs
174
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
174
Antiepileptic Drugs: Glutamate Antagonists
264
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
264


